BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 7148046)

  • 1. [Prognostic significance of histobiopsy findings in bone marrow of malignant lymphomas in adults].
    Günther C; Püschel W; Helbig W; Schwenke H; Kubel M; Hoffmann FA; Schultze W
    Z Gesamte Inn Med; 1982 Aug; 37(15):491-7. PubMed ID: 7148046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Value of Beckenkamm histobiopsy in the diagnosis of malignant lymphoma infiltrates in bone marrow].
    Günther C; Helbig W; Püschel W; Hofmann FA
    Z Gesamte Inn Med; 1982 Jul; 37(14):445-53. PubMed ID: 7136088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Iliac crest biopsy findings in malignant non-Hodgkin lymphoma].
    Günther C; Püschel W; Helbig W; Schneider D; Janke H
    Z Gesamte Inn Med; 1979 Aug; 34(15):suppl 193-5 contd concl. PubMed ID: 534369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone marrow involvement and the prognosis of low grade non-Hodgkin's lymphoma.
    Zemunik T; Vucković J; Marinković M; Forempoher G
    Croat Med J; 1998 Dec; 39(4):419-21. PubMed ID: 9841943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Bone marrow scintigraphy and magnetic resonance tomography in malignant lymphomas: comparison with histologic results].
    Linden A; Zankovich R; Theissen P; Schauerte G; Diehl V; Schicha H
    Nuklearmedizin; 1989 Oct; 28(5):166-71. PubMed ID: 2813080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical evaluation of bone marrow fibrosis in non-Hodgkin's lymphomas].
    Ishibashi M; Hisano S; Kimura N; Morioka E; Suzumiya J; Kawara T; Nakashima H; Uchida T; Okumura M; Kikuchi M
    Rinsho Ketsueki; 1992 Mar; 33(3):297-302. PubMed ID: 1578632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphoproliferative disorders in the bone marrow: histologic criteria for classification and staging.
    Bartl R; Frisch B; Hoffmann-Fezer G; Burkhardt R
    Haematologia (Budap); 1984; 17(2):227-46. PubMed ID: 6534830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone marrow lymphoid aggregates in malignant lymphomas.
    Dominis M; Pesut A; Borovecki A; Marusic-Vrsalovic M; Kusec R
    Croat Med J; 2005 Jun; 46(3):410-6. PubMed ID: 15861520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A review of histology of bone marrow trephine in malignant lymphomas.
    Durosinmi MA; Mabayoje VO; Akinola NO
    Niger J Med; 2003; 12(4):198-201. PubMed ID: 14768193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of aggressive non-Hodgkin's lymphoma with the ProMACE- CytaBOM protocol].
    Mihaljević B; Jancić-Nedeljkov R; Sretenović M; Milivojević G; Janković S; Petrović M
    Srp Arh Celok Lek; 1998; 126(9-10):345-8. PubMed ID: 9863405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histopathological trephine biopsy findings in cases of 'dry tap' bone marrow aspirations.
    Navone R; Colombano MT
    Appl Pathol; 1984; 2(5):264-71. PubMed ID: 6545669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of high numbers of intratumoral FOXP3+ regulatory T cells with improved survival in germinal center-like diffuse large B-cell lymphoma, follicular lymphoma and classical Hodgkin's lymphoma.
    Tzankov A; Meier C; Hirschmann P; Went P; Pileri SA; Dirnhofer S
    Haematologica; 2008 Feb; 93(2):193-200. PubMed ID: 18223287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [NMR tomographic imaging of bone marrow infiltrates in malignant lymphoma].
    Gückel F; Semmler W; Döhner H; Knauf W; Görich J; Ho AD; van Kaick G
    Rofo; 1989 Jan; 150(1):26-31. PubMed ID: 2536492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinico-pathological characteristics, response to therapy and survival of patients with bone marrow infiltration by Hodgkin's lymphoma].
    Marisavljević D; Bosković D; Petrović M; Colović M; Radosević-Radojković N; Jovanovitsh V
    Srp Arh Celok Lek; 1995; 123(3-4):68-72. PubMed ID: 16296226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Paraneoplastic lymphadenopathy].
    Melikian AL; Nikitin EA; Kaplanskaia IB; Frank GA
    Ter Arkh; 2007; 79(8):44-52. PubMed ID: 17926471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone marrow biopsy in staging of malignant lymphomas.
    Singh T; Harjinder ; Gaiha M
    J Assoc Physicians India; 1989 Aug; 37(8):513-4. PubMed ID: 2621187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allogeneic bone marrow transplantation for poor-prognosis lymphoma: response, toxicity and survival depend on disease histology.
    van Besien KW; Mehra RC; Giralt SA; Kantarjian HM; Pugh WC; Khouri IF; Moon Y; Williams P; Andersson BS; Przepiorka D; McCarthy PL; Gajewski JL; Deisseroth AB; Cabanillas FF; Champlin R
    Am J Med; 1996 Mar; 100(3):299-307. PubMed ID: 8629675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone marrow biopsy (BMB). III. Bone marrow biopsy in Hodgkin's disease (HD).
    Macavei I; Galatâr N
    Morphol Embryol (Bucur); 1990; 36(1):25-32. PubMed ID: 2149408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone marrow involvement in non-Hodgkin's lymphoma in Zimbabwe.
    Adewuyi B; Coutts A; Levy L; Klein S; Muronda C
    East Afr Med J; 1994 Dec; 71(12):773-5. PubMed ID: 7705245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.